PATENT CLAIM ANALYSIS

Application Number: 16109570
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["424", "186100"]

Abstract:
The present disclosure encompasses canine parvovirus (CPV) vaccines or compositions. The vaccine or composition may be a vaccine or composition containing CPV virus-like particle (VLP), and a preparation method and a use thereof. The CPV VLPs are formed by the CPV VP2 protein. Further, the disclosure broadly encompasses vaccines comprising combinations of MLV and VLP, which are capable of overcoming MDA against a variety of pathogens, which infect a variety of different species.

Claim (Index 17):
A method for eliciting a protective immune response in an animal against a pathogen comprising administering to the animal a MLV and VLPs in an amount effective to overcome a neutralizing effect of MDAs against the MLV, wherein the MLV and the VLPs are antigens from the pathogen.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 96.0
- Lexical Diversity: 1.66667
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15265545', '14863181', '15537081', '15317593', '13324887']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6990233388482199
- 35 USC 102 Novelty (BERT): 0.6076682913242235
- Combined Prediction Score: 0.6898878340958203
- Mean Citation Score: 316.0094640000001
- Max Citation Score: 613.0885599999998
- Similarity Product: 459.7494002740191

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test